THX Pharma Société Anonyme (EPA:ALTHX)
France · Delayed Price · Currency is EUR 4.235
-0.045 (-1.05%)
Aug 21, 2026, 5:35 PM CET
EPA:ALTHX Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.74 | 0.71 | 1.2 | 2.1 | 5.52 |
Short-Term Investments | 7.02 | 0.25 | 3.71 | 7 | 7.01 |
Cash & Short-Term Investments | 7.77 | 0.97 | 4.9 | 9.11 | 12.53 |
Cash Growth | 703.34% | -80.29% | -46.15% | -27.29% | 11.72% |
Accounts Receivable | 0.2 | 0.55 | 0 | 0.02 | 0.04 |
Other Receivables | 1.16 | 0.97 | 0.9 | 0.7 | 2.03 |
Receivables | 1.36 | 1.52 | 0.91 | 0.72 | 2.07 |
Prepaid Expenses | 0.01 | 0.02 | 0.01 | 0.7 | - |
Other Current Assets | 0.07 | 0.08 | 0.15 | -0 | 0.42 |
Total Current Assets | 9.22 | 2.58 | 5.97 | 10.53 | 15.02 |
Property, Plant & Equipment | 0.06 | 0.02 | 0.03 | 0.2 | 0.42 |
Long-Term Investments | 0.16 | 0.14 | 0.19 | 0.23 | 0.32 |
Other Intangible Assets | 1.11 | 1 | 1.05 | 1.09 | 1.14 |
Other Long-Term Assets | -0 | - | - | - | - |
Total Assets | 10.54 | 3.74 | 7.24 | 12.05 | 16.89 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.87 | 1.95 | 1.13 | 0.86 | 0.92 |
Accrued Expenses | 0.3 | 0.58 | 0.25 | 0.58 | 0.42 |
Short-Term Debt | - | 0.06 | - | - | - |
Current Portion of Long-Term Debt | 1.76 | - | 1.18 | 1.28 | 1.14 |
Total Current Liabilities | 3.93 | 2.59 | 2.56 | 2.72 | 2.48 |
Long-Term Debt | 1.12 | 2.81 | 2.46 | 3.61 | 4.19 |
Long-Term Unearned Revenue | 2 | - | - | - | - |
Other Long-Term Liabilities | 0.6 | - | -0 | - | 0.04 |
Total Liabilities | 7.64 | 5.4 | 5.02 | 6.33 | 6.71 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.14 | 2.13 | 1.94 | 1.34 | 1.26 |
Additional Paid-In Capital | 7.16 | 0.14 | 4.02 | 8.36 | 15.62 |
Retained Earnings | -5.31 | -4.57 | -6.83 | -6.57 | -8.15 |
Comprehensive Income & Other | 0.92 | 0.64 | 3.09 | 2.6 | 1.46 |
Shareholders' Equity | 2.9 | -1.66 | 2.22 | 5.73 | 10.18 |
Total Liabilities & Equity | 10.54 | 3.74 | 7.24 | 12.05 | 16.89 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.88 | 2.87 | 3.64 | 4.89 | 5.33 |
Net Cash (Debt) | 4.88 | -1.9 | 1.26 | 4.22 | 7.2 |
Net Cash Growth | - | - | -70.09% | -41.40% | 30.73% |
Net Cash Per Share | 0.35 | -0.22 | 0.16 | 0.79 | 1.43 |
Filing Date Shares Outstanding | 13.8 | 8.54 | 7.76 | 5.35 | 5.02 |
Total Common Shares Outstanding | 13.8 | 8.54 | 7.76 | 5.35 | 5.02 |
Working Capital | 5.29 | -0.01 | 3.41 | 7.81 | 12.54 |
Book Value Per Share | 0.21 | -0.19 | 0.29 | 1.07 | 2.03 |
Tangible Book Value | 1.8 | -2.66 | 1.17 | 4.64 | 9.05 |
Tangible Book Value Per Share | 0.13 | -0.31 | 0.15 | 0.87 | 1.80 |
Machinery | 0.53 | 0.84 | 1.03 | 1.06 | 1.02 |